There are two big reasons why Nick Lazaridis decided to join Gene Express as the company’s new president: “One is personalized medicine,” he says, “and the other is their technology.” That technology is the company’s StaRT-PCR platform, currently used by many clinical researchers for analysis of tissue, xenografts, and formalin-fixed paraffin embedded samples.